Should COVID-19 vaccination be postponed after acute myeloid leukemia therapy?

During the 63rd ASH Annual Meeting and Exposition, Know AML spoke with Sabine Haggenburg, Amsterdam UMC, Amsterdam, NL. We asked, Should COVID-19 vaccination be postponed after acute myeloid leukemia therapy?

Haggenburg begins by discussing COVID-19 risks to acute myeloid leukemia patients, and the responses to vaccinations that have been observed so far. However, she highlights that vaccination does not protect patients taking hypomethylating agents (HMAs), such as azacitidine and decitabine.

All content on Know AML is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the AML Hub.

Please get in touch if you have any questions about Know AML or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know AML. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know AML.

v2.29.00